Cost-Efficient Sequence-Based Nonextensible Oligonucleotide in Real-Time PCR and High-Throughput Sequencing
Kerou Zhang,Ping Song,Peng Dai,Jinny Xuemeng Zhang,Lucia Ruojia Wu,Lauren Yuxuan Cheng,Alessandro Pinto,Lawrence Kwong,Karina Cabrera,Ruoxin Wen,David Yu Zhang
DOI: https://doi.org/10.1021/acssensors.2c00183
IF: 8.9
2022-04-14
ACS Sensors
Abstract:Molecular detection of disease-associated mutations, especially those with low abundance, is essential for academic research and clinical diagnosis. Certain variant detection methods reach satisfactory sensitivity and specificity in detecting rare mutations based on the introduction of blocking oligos to prevent the amplification of wild-type or unwanted templates, thus selectively amplifying and enriching the mutations. These blocking oligos usually suppress PCR amplification through the 3′ chemical modifications, with high price, slow synthesis, and reduced purity. Herein, we introduce chemistry-free designs to block enzymatic extension during PCR by the steric hindrance from the secondary structures attached to the 3′ end of the oligos (nonextensible oligonucleotide, NEO). We demonstrated that NEO efficiently prohibited the extension of both Taq and high-fidelity DNA polymerases. By further applying NEO as blockers in blocker displacement amplification (BDA) qPCR, multiplex BDA (mBDA) NGS, and quantitative BDA (QBDA) NGS methods, we showed that NEO blockers had performance comparable with previously validated chemical modifications. Comparison experiments using QBDA with NEO blockers and droplet digital PCR (ddPCR) on clinical formalin-fixed paraffin-embedded (FFPE) samples exhibited 100% concordance. Lastly, the ability of NEO to adjust plex uniformity through changes of PCR amplification efficiency was demonstrated in an 80-plex NGS panel.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acssensors.2c00183.Extension blocking efficiency of some common chemical modifications; NEO structure exploration; performance of NEO with BDA in both qPCR and NGS; NEO QBDA, ddPCR, and NGS results of FFPE clinical samples; performance of NEO in the uniformity adjustment; design and utilization of NEO; sequence of the oligonucleotides (PDF)This article has not yet been cited by other publications.
chemistry, multidisciplinary, analytical,nanoscience & nanotechnology